Biogen's total assets for Q4 2024 were $28.05B, a decrease of -0.93% from the previous quarter. BIIB total liabilities were $11.33B for the fiscal quarter, a -5.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.